Next Article in Journal / Special Issue
Possibilities for RNA Interference in Developing Hepatitis C Virus Therapeutics
Previous Article in Journal / Special Issue
Cyclophilin Inhibitors as a Novel HCV Therapy
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(8), 1635-1646;

The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target

Laboratory of Virology and Infectious Disease, Center for the Study of Hepatitis C, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
Present address: International AIDS Vaccine Initiative (IAVI), AIDS Vaccine Design & Development Laboratory, Brooklyn Army Terminal, Building A Suite 8J, 140 58th Street, Brooklyn, NY 11220, USA
Received: 30 June 2010 / Revised: 3 August 2010 / Accepted: 4 August 2010 / Published: 6 August 2010
(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
Full-Text   |   PDF [131 KB, uploaded 12 May 2015]   |  


Infection with Hepatitis C Virus (HCV) continues to be a major global health problem. To overcome the limitations of current therapies using interferon-a in combination with ribavirin, there is a need to develop drugs that specifically block viral proteins. Highly efficient protease and polymerase inhibitors are currently undergoing clinical testing and will become available in the next few years. However, with resistance mutations emerging quickly, additional enzymatic activities or functions of HCV have to be targeted by novel compounds. One candidate molecule is the nonstructural protein 2 (NS2), which contains a proteolytic activity that is essential for viral RNA replication. In addition, NS2 is crucial for the assembly of progeny virions and modulates various cellular processes that interfere with viral replication. This review describes the functions of NS2 in the life cycle of HCV and highlights potential antiviral strategies involving NS2. View Full-Text
Keywords: nonstructural protein; dimer; protease; assembly; antiviral therapy nonstructural protein; dimer; protease; assembly; antiviral therapy

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Lorenz, I.C. The Hepatitis C Virus Nonstructural Protein 2 (NS2): An Up-and-Coming Antiviral Drug Target. Viruses 2010, 2, 1635-1646.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top